124 related articles for article (PubMed ID: 34999039)
1. Co-delivery of siRNA and lycopene encapsulated hybrid lipid nanoparticles for dual silencing of insulin-like growth factor 1 receptor in MCF-7 breast cancer cell line.
Mennati A; Rostamizadeh K; Manjili HK; Fathi M; Danafar H
Int J Biol Macromol; 2022 Mar; 200():335-349. PubMed ID: 34999039
[TBL] [Abstract][Full Text] [Related]
2. DDAB cationic lipid-mPEG, PCL copolymer hybrid nano-carrier synthesis and application for delivery of siRNA targeting IGF-1R into breast cancer cells.
Khodaei M; Rostamizadeh K; Taromchi AH; Monirinasab H; Fathi M
Clin Transl Oncol; 2021 Jun; 23(6):1167-1178. PubMed ID: 33389648
[TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC
Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane delivery using mPEG-PCL co-polymer nanoparticles to breast cancer cells.
Danafar H; Sharafi A; Kheiri Manjili H; Andalib S
Pharm Dev Technol; 2017 Aug; 22(5):642-651. PubMed ID: 26916923
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis induction by siRNA targeting integrin-β1 and regorafenib/DDAB-mPEG-PCL hybrid nanoparticles in regorafenib-resistant colon cancer cells.
Zhiani M; Mousavi MA; Rostamizadeh K; Pirizadeh R; Osali A; Mennati A; Motlagh B; Fathi M
Am J Cancer Res; 2021; 11(4):1170-1184. PubMed ID: 33948352
[TBL] [Abstract][Full Text] [Related]
6. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.
Nosrati H; Adinehvand R; Manjili HK; Rostamizadeh K; Danafar H
Pharm Dev Technol; 2019 Jan; 24(1):89-98. PubMed ID: 29307260
[TBL] [Abstract][Full Text] [Related]
9. Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells.
Shahidi S; Rostamizadeh K; Fathi M; Nedaei K; Ramazani A
BMC Complement Med Ther; 2022 Dec; 22(1):340. PubMed ID: 36575448
[TBL] [Abstract][Full Text] [Related]
10. Improved antitumor activity and reduced myocardial toxicity of doxorubicin encapsulated in MPEG-PCL nanoparticles.
Sun C; Zhou L; Gou M; Shi S; Li T; Lang J
Oncol Rep; 2016 Jun; 35(6):3600-6. PubMed ID: 27109195
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes.
Erdemli Ö; Özen S; Keskin D; Usanmaz A; Batu ED; Atilla B; Tezcaner A
J Biomater Appl; 2014 Oct; 29(4):524-42. PubMed ID: 24854983
[TBL] [Abstract][Full Text] [Related]
12. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection.
Jang JS; Kim SY; Lee SB; Kim KO; Han JS; Lee YM
J Control Release; 2006 Jun; 113(2):173-82. PubMed ID: 16750279
[TBL] [Abstract][Full Text] [Related]
13. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
14. Surface modification of MPEG-b-PCL-based nanoparticles via oxidative self-polymerization of dopamine for malignant melanoma therapy.
Xiong W; Peng L; Chen H; Li Q
Int J Nanomedicine; 2015; 10():2985-96. PubMed ID: 25945046
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of monomethoxy poly(ethylene glycol)-poly (ε-caprolactone) micelle-encapsulated doxorubicin against mouse melanoma.
Zheng L; Gou M; Zhou S; Yi T; Zhong Q; Li Z; He X; Chen X; Zhou L; Wei Y; Qian Z; Zhao X
Oncol Rep; 2011 Jun; 25(6):1557-64. PubMed ID: 21455590
[TBL] [Abstract][Full Text] [Related]
16. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of doxorubicin conjugated methoxy poly(ethylene glycol)-block-poly(ε-caprolactone) nanoparticles and study on their
Shen H; Liu Q; Liu D; Yu S; Wang X; Yang M
J Biomater Sci Polym Ed; 2021 Sep; 32(13):1703-1717. PubMed ID: 34075850
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of etoposide, carmustine and doxorubicin to human glioblastoma cells using methoxy poly(ethylene glycol)‑poly(ε‑caprolactone) nanoparticles conjugated with wheat germ agglutinin and folic acid.
Kuo YC; Chang YH; Rajesh R
Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():114-128. PubMed ID: 30606517
[TBL] [Abstract][Full Text] [Related]
19. Stable loading and delivery of disulfiram with mPEG-PLGA/PCL mixed nanoparticles for tumor therapy.
Song W; Tang Z; Lei T; Wen X; Wang G; Zhang D; Deng M; Tang X; Chen X
Nanomedicine; 2016 Feb; 12(2):377-86. PubMed ID: 26711966
[TBL] [Abstract][Full Text] [Related]
20. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.
Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL
Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
